(PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation
Clinical trial NCT04811365 · COMPLETED
Trial details
- NCT number
- NCT04811365
- Sponsor
- Blueprint Medicines Corporation
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-29
- Primary completion
- 2023-03-31
- Enrollment
- 379
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.